Literature DB >> 6379135

Genetically determined variation in the complement system: relationship to disease.

R H McLean, J A Winkelstein.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6379135     DOI： 10.1016/s0022-3476(84)80110-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  Genetic studies of low abundance human plasma proteins. III. Polymorphism of the C1R subcomponent of the first complement component.

Authors:  M I Kamboh; R E Ferrell
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

2.  Haplotype study on C4 polymorphism in Japanese. Associations with MHC alleles, complotypes, and HLA-complement haplotypes.

Authors:  K Tokunaga; K Omoto; T Akaza; N Akiyama; H Amemiya; S Naito; T Sasazuki; H Satoh; T Juji
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Molecular analysis of C3 allotypes in patients with nephritic factor.

Authors:  J E Finn; P W Mathieson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

4.  Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third component of complement.

Authors:  A M Roodhooft; R H McLean; E Elst; K J Van Acker
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  Hereditary partial deficiency of the third component of complement associated with minimal change nephrotic syndrome.

Authors:  J E Springate; R H McLean; J A Winkelstein; L G Feld
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

Review 6.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

7.  C3 R102G polymorphism increases risk of age-related macular degeneration.

Authors:  Kylee L Spencer; Lana M Olson; Brent M Anderson; Nathalie Schnetz-Boutaud; William K Scott; Paul Gallins; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Hum Mol Genet       Date:  2008-03-06       Impact factor: 6.150

Review 8.  New approaches to the treatment of dense deposit disease.

Authors:  Richard J H Smith; Jessy Alexander; Paul N Barlow; Marina Botto; Thomas L Cassavant; H Terence Cook; Santiago Rodriguez de Córdoba; Gregory S Hageman; T Sakari Jokiranta; William J Kimberling; John D Lambris; Lynne D Lanning; Vicki Levidiotis; Christoph Licht; Hans U Lutz; Seppo Meri; Matthew C Pickering; Richard J Quigg; Angelique L Rops; David J Salant; Sanjeev Sethi; Joshua M Thurman; Hope F Tully; Sean P Tully; Johan van der Vlag; Patrick D Walker; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2007-08-05       Impact factor: 10.121
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.